Pharmaceuticals

Custom Antibody Industry Forecast to Hit $0.76 Billion by 2029 With a Strong 12.8% CAGR

November 11, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Custom Antibody Market Size During 2025–2029?

The custom antibody market has demonstrated rapid expansion in recent years. Its size is expected to increase from $0.42 billion in 2024 to $0.47 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.6%. This historical progression is largely due to factors such as an escalating demand for custom antibodies, the increasing adoption of precision medicine, a rise in the incidence of chronic diseases and cancer, a surge in research and development activities, and an expanding number of clinical trials.

The custom antibody market size is anticipated to expand rapidly in the coming years, reaching $0.76 billion by 2029 with a compound annual growth rate (CAGR) of 12.8%. This growth throughout the forecast period is primarily attributed to the increasing adoption of targeted immunotherapy, growing investment in biopharmaceuticals, the rising prevalence of neurodegenerative diseases, increasing demand for in vitro diagnostics (IVD) applications, and increasing healthcare expenditures. Significant trends during the forecast period encompass personalized medicine, technological advancements in antibody engineering, progress in biotechnology and genetic engineering, expanding therapeutic applications, and technological advancements in the purification of antibodies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21162&type=smp

What Are The Main Drivers Boosting The Custom Antibody Industry’s Expansion?

The increasing need for personalized medical approaches is projected to drive expansion within the custom antibody market in the future. Personalized medicine is a medical strategy that customizes treatment and prevention methods according to an individual’s unique genetic profile, lifestyle, and surrounding environmental elements. This rising demand stems from progress in genomics, a greater availability of therapies centered on biomarkers, and a growing patient preference for customized treatments that enhance effectiveness and minimize negative side effects. Custom antibody facilitates personalized medicine through the provision of specific and custom-made immune reagents, which improve the detection of diseases, targeting of therapies, and identification of biomarkers for individual treatment plans. As an illustration, the Personalized Medicine Coalition, a US-based non-profit organization, reported in February 2024 that the Food and Drug Administration (FDA) gave its approval to 16 novel personalized treatments for patients with rare diseases in 2023, marking an increase from 6 approvals in 2022. Consequently, the escalating requirement for personalized medicine is fueling the expansion of the custom antibody market.

Which Key Segments Fueling The Custom Antibody Market?

The custom antibody market covered in this report is segmented –

1) By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Types

2) By Service: Antibody Development, Antibody Production And Purification, Antibody Fragmentation And Labeling

3) By Source: Mice, Rabbit, Other Sources

4) By Application: Oncology, Infectious Diseases, Neurology, Stem Cells, Immunology, Cardiovascular Diseases, Other Applications

5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organization, Hospitals And Clinics

Subsegments:

1) By Monoclonal Antibodies: Murine Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies, Goat Polyclonal Antibodies, Sheep Polyclonal Antibodies, Other Animal-Derived Polyclonal Antibodies

3) By Recombinant Antibodies: Single-Chain Variable Fragment (scFv), Nanobodies, Bispecific Antibodies, Antibody Fragments

4) By Other Types: Aptamers, Nanobodies (Camelid Antibodies), Hybridomas

Which Key Trends Are Expected To Influence The Custom Antibody Market In The Coming Years?

Leading companies within the custom antibody market are concentrating on incorporating innovative technologies, such as artificial intelligence, to improve antibody discovery, enhance specificity, and accelerate development processes. Artificial intelligence supports custom antibody development by refining antigen selection, predicting antibody-antigen binding, and streamlining candidate screening through machine learning, leading to quicker and more cost-effective biopharmaceutical research. For instance, in October 2024, Archon Biosciences Inc., a US-based biotechnology company, commenced operations with $20 million in funding to develop computationally designed antibody cages that enable the customization of existing antibodies for therapeutic applications. Archon’s proprietary technology constructs antibodies into cage structures, permitting modifications to their properties without altering their fundamental structures. This innovation aims to heighten antibody affinity for therapeutic targets while simultaneously reducing off-target interactions, thereby improving efficacy and safety.

Which Major Firms Are Strengthening Their Position In The Custom Antibody Industry?

Major companies operating in the custom antibody market are Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, BioLegend Inc., Abcam plc, Cusabio Biotech Co. Ltd., OriGene Technologies Inc., Cell Signaling Technology Inc., Abgent Inc., ProSci Incorporated, Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Biorbyt Ltd., BIOTEM SAS, Capra Biosciences Inc., Pacific Immunology Inc., ProteoGenix SAS

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/custom-antibody-global-market-report

How Does The Custom Antibody Market Perform Across Key Geographic Regions?

North America was the largest region in the custom antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the custom antibody market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Custom Antibody Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21162&type=smp

Browse Through More Reports Similar to the Global Custom Antibody Market 2025, By The Business Research Company

Antibody Drug Conjugates Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

Antibody Contract Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report

Next Generation Antibody Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-antibody-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795